Form 8-K - Current report:
SEC Accession No. 0000950170-21-005140
Filing Date
2021-12-10
Accepted
2021-12-10 16:20:11
Documents
21
Period of Report
2021-12-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acet-20211207.htm   iXBRL 8-K 68125
2 EX-1.1 acet-ex1_1.htm EX-1.1 434597
3 EX-5.1 acet-ex5_1.htm EX-5.1 15515
4 EX-99.1 acet-ex99_1.htm EX-99.1 15847
5 EX-99.2 acet-ex99_2.htm EX-99.2 14536
6 GRAPHIC img95647733_0.jpg GRAPHIC 3771
7 GRAPHIC img208765579_0.jpg GRAPHIC 12399
8 GRAPHIC img95647733_1.jpg GRAPHIC 1853
9 GRAPHIC img94724212_0.jpg GRAPHIC 3771
10 GRAPHIC img94724212_1.jpg GRAPHIC 1853
  Complete submission text file 0000950170-21-005140.txt   788617

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acet-20211207_lab.xml EX-101.LAB 19138
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acet-20211207_pre.xml EX-101.PRE 11504
13 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acet-20211207.xsd EX-101.SCH 2495
14 EXTRACTED XBRL INSTANCE DOCUMENT acet-20211207_htm.xml XML 4877
Mailing Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116
Business Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 211485592
SIC: 2834 Pharmaceutical Preparations